首页> 外文期刊>European journal of clinical microbiology and infectious diseases: Official publication of the European Society of Clinical Microbiology >Evaluation of the sensitivity of IgG and IgM ELISA in detecting Schistosoma mansoni infections in a low endemicity setting
【24h】

Evaluation of the sensitivity of IgG and IgM ELISA in detecting Schistosoma mansoni infections in a low endemicity setting

机译:在低流行性环境中IgG和IgM ELISA在检测曼氏血吸虫感染中的敏感性评估

获取原文
获取原文并翻译 | 示例
       

摘要

Schistosomiasis is a major public health concern, with 200 million people infected worldwide. In Brazil, this disease has been reported in 19 states, and its prevalence in the city of Barra Mansa in Rio de Janeiro State is 1 %. The parasitological diagnostic methods currently available in these areas lack sensitivity; however, enzyme-linked immunosorbent assays (ELISAs) have been employed successfully for the diagnosis of schistosomiasis by using antibodies against antigens of Schistosoma mansoni adult worms and eggs, and for the detection of circulating antigens. The objective of this study was to determine systematically the prevalence of S. mansoni infection in the peripheral areas of Barra Mansa. A cross-sectional study was conducted from April to December 2011 by using probabilistic sampling that collected 610 fecal samples and 612 serum samples. ELISA-IgG with total extracts and ELISA-IgM with trichloroacetic acid-soluble fractions were employed to detect antibodies against S. mansoni and were compared with the Kato-Katz and Hoffman parasitological techniques. Among the individuals studied, anti-S. mansoni antibodies were detected in 11.16 % (n = 71) by ELISA-IgG and in 20.75 % (n = 132) by ELISA-IgM, while the parasitological techniques showed 0.82 % (n = 5) positivity. The agreement between the two ELISA tests was 85.38 % (n = 543), and 8.65 % (n = 55) of the serum samples showed positive results in both tests. The higher positivity of the ELISA-IgM test corroborates the results of previous reports and indicates that the test may be a useful tool in epidemiological studies, particularly in areas of low endemicity for S. mansoni.
机译:血吸虫病是主要的公共卫生问题,全世界有2亿人受到感染。在巴西,已有19个州报告了该病,在里约热内卢州的巴拉曼萨市的流行率为1%。这些地区目前可用的寄生虫学诊断方法缺乏敏感性。然而,酶联免疫吸附测定法(ELISAs)已成功通过使用针对曼氏血吸虫成虫和卵抗原的抗体来诊断血吸虫病,并已成功用于循环抗原的检测。这项研究的目的是系统地确定巴拉曼萨(Barra Mansa)周边地区曼氏沙门氏菌感染的患病率。 2011年4月至2011年12月,采用概率抽样进行了横断面研究,该概率抽样收集了610份粪便样本和612份血清样本。使用总提取物的ELISA-IgG和三氯乙酸可溶级分的ELISA-IgM检测抗曼氏沙门氏菌的抗体,并与Kato-Katz和Hoffman寄生虫学技术进行比较。在研究的个体中,抗-S。 ELISA-IgG检测到mansoni抗体的比例为11.16%(n = 71),ELISA-IgM检测到的mansoni抗体的比例为20.75%(n = 132),而寄生虫技术显示为0.82%(n = 5)阳性。两次ELISA测试之间的一致性为85.38%(n = 543),并且8.65%(n = 55)的血清样品在两个测试中均显示阳性结果。 ELISA-IgM检测的较高阳性结果证实了先前报道的结果,并表明该检测可能是流行病学研究中的有用工具,特别是在曼氏沙门氏菌流行性较低的地区。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号